🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Preventive Treatment of Migraine

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine NCT07159750n/a26 sites📍 Miami📍 Buenos Aires📍 Santiago Hospital Universitari Vall d'Hebron Research Institute · Tests: CGRP antibody or gepant Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old NCT04748601Phase 415 sites📍 Birmingham📍 La Jolla📍 Aurora Upsher-Smith Laboratories · Tests: Qudexy XR, Placebo Closed-loop RTMS for Short-term Migraine Prevention NCT06735768NA1 site📍 Vienna Brightmind.AI · Tests: rTMS treatment, Determination of motor hotspot and motor treshold Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine NCT07279623NA1 site📍 Stockholm Abilion Medical Systems AB · Tests: INMEST-treatment Prophylactic Treatment With Atorvastatin for Episodic Migraine. NCT06248671Phase 26 sites📍 Bergen📍 Lørenskog📍 Oslo St. Olavs Hospital · Tests: Atorvastatin 40mg, Placebo, Atorvastatin 20mg Neuro-Complex & Multi Supplements for Migraine Prevention NCT07015411NA1 site📍 Mechelen Benfida, a department of Handi-Move · Tests: Neuro-Complex and Multi nVNS for the Prevention and Treatment of Primary Headache NCT06277063NA1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Transcutaneous auricular vagus nerve stimulation i-NEED: NEw migrainE Drugs Database NCT07103694n/a2 sites📍 Milan📍 Rome IRCCS San Raffaele Roma · Tests: anti-CGRP monoclonal antibodies, gepants, combination of sumatriptan and naproxen, ditan A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine NCT07729462Phase 321 sites📍 Scottsdale📍 Canoga Park📍 Fresno Pfizer · Tests: Rimegepant, Placebo A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine NCT06641466Phase 3123 sites📍 Phoenix📍 Phoenix📍 Scottsdale Pfizer · Tests: Rimegepant, Placebo Comparator, Standard of Care, Rimegepant The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine NCT07023926NA1 site📍 Beijing Guang'anmen Hospital of China Academy of Chinese Medical Sc… · Tests: electroacupuncture, Sham electroacupuncture A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years NCT06810505Phase 366 sites📍 Huntsville📍 Fayetteville📍 Little Rock AbbVie · Tests: Atogepant, Placebo for Atogepant Idebenone for the Preventive Treatment of Migraine NCT04151472Phase 31 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Placebo, 90mg Idebenone, 270mg Idebenone Study of EVO756 in Adults With Migraine NCT07616128Phase 235 sites📍 Chandler📍 Buena Park📍 Fresno Evommune, Inc. · Tests: EVO756, Dose 1, EVO756, Dose 2, Placebo Cannabis for the Prophylactic Treatment of Migraine NCT03972124Phase 21 site📍 Calgary University of Calgary · Tests: CBD 100 mg OD, CBD 200 mg OD, Placebo Tai Chi and Acupuncture on Migraine Attack Prevention and Brain White Matter Changes NCT06967909NA1 site📍 Hung Hom The Hong Kong Polytechnic University · Tests: Tai Chi training, Acupuncture Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig) NCT06485336Phase 26 sites📍 Bergen📍 Lørenskog📍 Oslo St. Olavs Hospital · Tests: Atorvastatin 40mg, Placebo Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects NCT05156398Phase 393 sites📍 Fort Smith📍 Hawthorne📍 La Mesa Pfizer · Tests: Rimegepant, Placebo Cabergoline for Episodic Migraine NCT07072910Phase 21 site📍 Aarhus N Aarhus University Hospital · Tests: Cabergoline 0.5 MG, Placebo, Cabergoline 1 MG MMA Embolization for Refractory Chronic Migraine NCT06735833NA8 sites📍 Walnut Creek📍 Hartford📍 Buffalo Cerenovus, Part of DePuy Synthes Products, Inc. · Tests: Middle Meningeal Artery embolization A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine NCT04965675Phase 379 sites📍 New Haven📍 Stamford📍 Washington D.C. H. Lundbeck A/S · Tests: Eptinezumab, Placebo Efficacy of Nerve Blocks for Episodic Migraine NCT05734625Phase 21 site📍 Rochester Mayo Clinic · Tests: Bupivacaine HCl 0.5% Injectable Solution, Methylprednisolone 40 MG Injection Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura NCT04063540Phase 25 sites📍 Bron📍 Clermont-Ferrand📍 Marly Centre Hospitalier Universitaire de Nice · Tests: Amiloride, Placebos Sleep, Stress and Migraine - an Observational and Training Study NCT07573488NA1 site📍 Zurich Susanne Wegener · Tests: Profile-based behavioral sleep and stress management Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents NCT07267819n/a1 site📍 Bethesda Uniformed Services University of the Health Sciences · Tests: Xeomin (incobotulinumtoxinA) Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine NCT06603558n/a36 sites📍 Busan📍 Busan📍 Busan AbbVie · Tests: Atogepant Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications NCT06401642Phase 41 site📍 Phoenix Mayo Clinic · Tests: Zavegepant Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study NCT06972056Phase 437 sites📍 Hazel Green📍 Flagstaff📍 Phoenix Mayo Clinic · Tests: Atogepant 60 mg, Propranolol 160 mg, Topiramate 100 mg A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine NCT05711394Phase 398 sites📍 Huntsville📍 Saraland📍 Little Rock AbbVie · Tests: Atogepant, Placebo-Matching Atogepant Fremanezumab for the Prevention of Menstrually-related Migraine Attacks NCT06659120n/a1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Fremanezumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy